Cancer Research

Journal

Publication Venue For

  • Loss of FOXP3 and TSC1 Accelerates Prostate Cancer Progression through Synergistic Transcriptional and Posttranslational Regulation of c-MYC..  79:1413-1425. 2019
  • Spleen tyrosine kinase-mediated autophagy is required for epithelial-mesenchymal plasticity and metastasis in breast cancer. 2019
  • Retraction: (–)-epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12–dependent DNA repair (Cancer Research (2006) 66 (5512–5520) DOI: 10.1158/0008-5472.CAN-06-0218).  78:6709. 2018
  • Retraction: Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors (Cancer Research (2007) 67 (3785–3793) DOI: 10.1158/0008-5472.CAN-06-3134).  78:6708. 2018
  • Discovery and characterization of dual inhibitors of MDM2 and NFAT1 for pancreatic cancer therapy.  78:5656-5667. 2018
  • Determination of tumor margins with surgical specimen mapping using near-infrared fluorescence.  78:5144-5154. 2018
  • Combined c-Met/Trk inhibition overcomes resistance to CDK4/6 inhibitors in Glioblastoma.  78:4360-4369. 2018
  • Pathology, chemoprevention, and preclinical models for target validation in Barrett esophagus.  78:3747-3754. 2018
  • Activation of the receptor tyrosine kinase AXL regulates the immune microenvironment in glioblastoma.  78:3002-3013. 2018
  • Hiding in plain sight: Rediscovering the importance of noncoding RNA in human malignancy.  78:2149-2158. 2018
  • Inactivation of cancer-associated-fibroblasts disrupts oncogenic signaling in pancreatic cancer cells and promotes its regression.  78:1321-1333. 2018
  • YAP1 and COX2 coordinately regulate urothelial cancer stem-like cells.  78:168-181. 2018
  • Mitochondrial haplotype alters mammary cancer tumorigenicity and metastasis in an oncogenic driver–dependent manner.  77:6941-6949. 2017
  • Mitochondrial genomic backgrounds affect nuclear DNA methylation and gene expression.  77:6202-6214. 2017
  • STRAP promotes stemness of human colorectal cancer via epigenetic regulation of the NOTCH pathwaya.  77:5464-5478. 2017
  • Transglutaminase 2 inhibition reverses mesenchymal transdifferentiation of glioma stem cells by regulating C/EBPβ signaling.  77:4973-4984. 2017
  • Regulatory aspects of optical methods and exogenous targets for cancer detection.  77:2197-2206. 2017
  • Bone metastasis of prostate cancer can be therapeutically targeted at the TBX2-WNT signaling axis.  77:1331-1344. 2017
  • Mutational landscape and gene expression patterns in adult acute myeloid Leukemias with Monosomy 7 as a sole abnormality.  77:207-218. 2017
  • FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells.  76:7219-7230. 2016
  • Syndecan-1 (CD138) suppresses apoptosis in multiple myeloma by activating IGF1 receptor: Prevention by synstatinIGF1R inhibits tumor growth.  76:4981-4993. 2016
  • PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis.  76:4430-4442. 2016
  • The tumor-associated glycosyltransferase ST6Gal-I regulates stem cell transcription factors and confers a cancer stem cell phenotype.  76:3978-3988. 2016
  • Extracellular vesicles from high-grade glioma exchange diverse pro-oncogenic signals that maintain intratumoral heterogeneity.  76:2876-2881. 2016
  • Tumor cell invasion-not all barriers are created equal.  76:1675-1676. 2016
  • Tumor heterogeneity - A 'contemporary concept' founded on historical insights and predictions.  76:4-6. 2016
  • Essential components of cancer education.  75:5202-5205. 2015
  • Androgen-regulated SPARCL1 in the tumor microenvironment inhibits metastatic progression.  75:4322-4334. 2015
  • Mitochondrial genetics regulate breast cancer Tumorigenicity and Metastatic potential.  75:4429-4436. 2015
  • KAP1 promotes proliferation and metastatic progression of breast cancer cells.  75:344-355. 2015
  • FOXP3 controls an MIR-146/NF-κB negative feedback loop that inhibits apoptosis in breast cancer cells.  75:1703-1713. 2015
  • FOXP3-MIR-146-NF-κB axis and therapy for precancerous lesions in prostate.  75:1714-1724. 2015
  • Identification of variant-specific functions of PIK3CA by rapid phenotyping of rare mutations.  75:5341-5354. 2015
  • SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signaling.  74:6318-6329. 2014
  • β-catenin contributes to lung tumor development induced by EGFR mutations.  74:5891-5902. 2014
  • Sonic hedgehog signaling in basal cell nevus syndrome.  74:4967-4975. 2014
  • Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.  74:4482-4492. 2014
  • Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma.  74:1718-1727. 2014
  • Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1.  74:738-750. 2014
  • Metastasis suppressor KISS1Seemsto reverse the warburg effect by enhancing mitochondrial biogenesis.  74:954-963. 2014
  • TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.  73:7162-7167. 2013
  • Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways.  73:6609-6620. 2013
  • Adenomatous polyps are drivenbymicrobe-instigated focal inflammation and are controlled by IL-10-producing T cells.  73:5905-5913. 2013
  • TGF-β Modulates ovarian cancer invasion by upregulating CAF-Derived versican in the tumor microenvironment.  73:5016-5028. 2013
  • Aptamer identification of brain tumor-initiating cells.  73:4923-4936. 2013
  • Myeloid-derived suppressor cells as osteoclast progenitors: A novel target for controlling osteolytic bone metastasis.  73:4606-4610. 2013
  • 4-hydroxytamoxifen induces autophagic death through K-Ras degradation.  73:4395-4405. 2013
  • Abstract 4604: Landscape of human and viral genomic alterations in cervical carcinomas..  73:4604-4604. 2013
  • FOXP3 Regulates Sensitivity of Cancer Cells to Irradiation by Transcriptional Repression of BRCA1.  73:2170-2180. 2013
  • ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.  73:2368-2378. 2013
  • Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1.  73:1211-1218. 2013
  • Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.  73:672-682. 2013
  • Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.  72:6425-6434. 2012
  • Targeting BRCA1 localization to augment breast tumor sensitivity to poly(ADP-Ribose) polymerase inhibition.  72:5547-5555. 2012
  • RAP80 is critical in maintaining genomic stability and suppressing tumor development.  72:5080-5090. 2012
  • HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair.  72:4796-4806. 2012
  • Ovarian cancer risk associated with inherited inflammation- related variants.  72:1064-1069. 2012
  • Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.  72:917-927. 2012
  • Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis.  72:133-143. 2012
  • Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.  71:6184-6194. 2011
  • CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.  71:5522-5534. 2011
  • TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers.  71:5387-5392. 2011
  • p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage.  71:5546-5557. 2011
  • The Mef/Elf4 transcription factor fine tunes the DNA damage response.  71:4857-4865. 2011
  • An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer.  71:3812-3821. 2011
  • LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.  71:3896-3903. 2011
  • Abstract 949: PathSeq: A comprehensive computational tool for pathogen discovery by deep sequencing of human cancer tissues.  71:949-949. 2011
  • β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.  71:2600-2610. 2011
  • Identification of a Tumor Suppressor Relay between the FOXP3 and the Hippo Pathways in Breast and Prostate Cancers.  71:2162-2171. 2011
  • Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition.  70:10002-10011. 2010
  • Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL.  70:8329-8338. 2010
  • Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis.  70:6566-6576. 2010
  • DNA damage-induced cytotoxicity is dissociated from BRCA1's DNA repair function but is dependent on its cytosolic accumulation.  70:6258-6267. 2010
  • Activation of NF-κB signaling by inhibitor of NF-κB kinase β increases aggressiveness of ovarian cancer.  70:4005-4014. 2010
  • Smad signaling is required to maintain epigenetic silencing during breast cancer progression.  70:968-978. 2010
  • Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase..  69:9192-9201. 2009
  • Correction: Glomus tumors in neurofibromatosis type 1: Genetic, functional, and clinical evidence of a novel association (Cancer Research (2009) 69, (7393-7401)).  69:8216. 2009
  • Glomus tumors in neurofibromatosis type 1: Genetic, functional, and clinical evidence of a novel association.  69:7393-7401. 2009
  • Metastamir: The field of metastasis-regulatory microRNA is spreading.  69:7495-7498. 2009
  • Plasminogen kringle 5 induces apoptosis of brain microvessel endothelial cells: Sensitization by radiation and requirement for GRP78 and LRP1.  69:5537-5545. 2009
  • β 1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1.  69:5374-5382. 2009
  • NORE1A tumor suppressor candidate modulates p21CIP1 via p53.  69:4629-4637. 2009
  • Cyclophosphamide augments antitumor immunity: Studies in an autochthonous prostate cancer model.  69:4309-4318. 2009
  • The miR-17/92 Polycistron Is Up-regulated in Sonic Hedgehog-Driven Medulloblastomas and Induced by N-myc in Sonic Hedgehog-Treated Cerebellar Neural Precursors.  69:3249-3255. 2009
  • Tumor-Infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-Arginine metabolism.  69:3086-3094. 2009
  • FOXP3 Up-regulates p21 Expression by Site-Specific Inhibition of Histone Deacetylase 2/Histone Deacetylase 4 Association to the Locus.  69:2252-2259. 2009
  • Breast cancer metastasis suppressor 1 up-regulates miR-146, Which suppresses breast cancer metastasis.  69:1279-1283. 2009
  • Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors.  69:554-564. 2009
  • Effects of methyl derivatives of the rexinoid UAB30 on methyinitrosourea (MNU) induced mammary cancers and on various indicators of toxicity..  69:138S-138S. 2009
  • Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development.  69:678-686. 2009
  • Approaches to complex pathways in molecular epidemiology: Summary of a special conference of the american association for cancer research.  68:10028-10030. 2008
  • Effects of dasatinib on Src kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.  68:9624-9633. 2008
  • Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells.  68:9141-9146. 2008
  • A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: Involvement of nuclear factor-κB signaling.  68:8564-8572. 2008
  • A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice.  68:8555-8563. 2008
  • Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenograftsby diffusion-weighted magnetic resonance imaging.  68:8369-8376. 2008
  • Bone marrow X kinase-mediated signal transduction in irradiated vascular endothelium (Cancer Research (2008) 68, (2861-2869)).  68:8189. 2008
  • Regulation of estrogenic effects by beclin 1 in breast cancer cells.  68:7855-7863. 2008
  • A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: Identification of DDX5-ETV4 fusion protein in prostate cancer.  68:7629-7637. 2008
  • Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl alcohol.  68:7439-7447. 2008
  • Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations.  68:6789-6796. 2008
  • Targeting cancer stem cells through L1CAM suppresses glioma growth.  68:6043-6048. 2008
  • Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors.  68:6232-6240. 2008
  • A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.  68:5478-5486. 2008
  • RAP80 responds to DNA damage induced by both ionizing radiation and UV irradiation and is phosphorylated at Ser205.  68:4269-4276. 2008
  • Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice.  68:4340-4346. 2008
  • Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis.  68:3924-3930. 2008
  • Bone marrow X kinase-mediated signal transduction in irradiated vascular endothelium.  68:2861-2869. 2008
  • Identification of p18INK4c as a tumor suppressor gene in glioblastoma multiforme.  68:2564-2569. 2008
  • Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis (Cancer Research (2008) 68, (615-622)).  68:1609. 2008
  • Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.  68:1012-1021. 2008
  • Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.  68:674-682. 2008
  • Cannabinoids for cancer treatment: Progress and promise.  68:339-342. 2008
  • Protective role of toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.  68:615-622. 2008
  • Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.  68:73-80. 2008
  • Aurora-A kinase regulates breast cancer-associated gene 1 inhibition of centrosome-dependent microtubule nucleation.  67:11186-11194. 2007
  • Cks1 regulates cdk1 expression: A novel role during mitotic entry in breast cancer cells.  67:11393-11401. 2007
  • A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.  67:10657-10663. 2007
  • Genetic determinants of mitochondrial response to arsenic in yeast Saccharomyces cerevisiae.  67:9740-9749. 2007
  • Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.  67:9407-9416. 2007
  • Erratum: SIRT1 is significantly elevated in mouse and human prostate cancer (Cancer Research (2007) 67, (6612-6618)).  67:8423. 2007
  • Inactivation of Smad4 accelerates KrasG12D-mediated pancreatic neoplasia.  67:8121-8130. 2007
  • SIRT1 is significantly elevated in mouse and human prostate cancer (vol 67, pg 6612, 2007).  67:8423-8423. 2007
  • Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response.  67:7929-7936. 2007
  • A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors.  67:7505-7511. 2007
  • Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase..  67:7194-7202. 2007
  • BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia.  67:7045-7053. 2007
  • Proteomics-based identification of proteins secreted in apical surface fluid of squamous metaplastic human tracheobronchial epithelial cells cultured by three-dimensional organotypic air-liquid interface method.  67:6565-6573. 2007
  • SIRT1 is significantly elevated in mouse and human prostate cancer.  67:6612-6618. 2007
  • The ubiquitin-interacting motif-containing protein RAP80 interacts with BRCA1 and functions in DNA damage repair response.  67:6647-6656. 2007
  • Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer.  67:6136-6145. 2007
  • Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP ,model.  67:5789-5797. 2007
  • Adenovirus tumor targeting and hepatic untargeting by a coxsackie/adenovirus receptor ectodomain anticarcinoembryonic antigen bispecific adapter.  67:5354-5361. 2007
  • HIV protease inhibitors enhance the efficacy of irradiation.  67:4886-4893. 2007
  • Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors.  67:3785-3793. 2007
  • Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.  67:3461-3467. 2007
  • Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice.  67:3475-3482. 2007
  • Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.  67:1757-1768. 2007
  • Smad4 regulates claudin-1 expression in a transforming growth factor-β-independent manner in colon cancer cells.  67:1571-1579. 2007
  • Growth factor stimulation reduces residual quiescent chronic myelogenous leukemia progenitors remaining after imatinib treatment.  67:1113-1120. 2007
  • Cancer progression in the transgenic adenocarcinoma of mouse prostate mouse is related to energy balance, body mass, and body composition, but not food intake.  67:417-424. 2007
  • Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma.  67:22-25. 2007
  • Ataxia telangiectasia mutated down-regulates phospho-extracellular signal-regulated kinase 1/2 via activation of MKP-1 in response to radiation.  66:11554-11559. 2006
  • Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with β-catenin activation.  66:11967-11974. 2006
  • Oncogenic serine-threonine kinase receptor-associated protein modulates the function of ewing sarcoma protein through a novel mechanism.  66:10824-10832. 2006
  • β2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis.  66:9108-9116. 2006
  • AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.  66:8722-8730. 2006
  • Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-β signaling in ovarian cancer.  66:8404-8412. 2006
  • Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function.  66:8520-8528. 2006
  • Mechanism of action of sulforaphane: Inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells.  66:8804-8813. 2006
  • BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis.  66:8182-8191. 2006
  • Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.  66:7843-7848. 2006
  • Papilloma development is delayed in osteopontin-null mice: Implicating an antiapoptosis role for osteopontin.  66:7119-7127. 2006
  • The primary cilium in cell signaling and cancer.  66:6463-6467. 2006
  • Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis.  66:6156-6166. 2006
  • A systems approach to model metastatic progression.  66:5537-5539. 2006
  • (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair.  66:5512-5520. 2006
  • Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.  66:2500-2505. 2006
  • Molecular target-based therapy of pancreatic cancer.  66:2403-2413. 2006
  • Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells.  66:2257-2263. 2006
  • Erratum: Promotion of invasion and metastatic potential by Bcl-2 (Cancer Research (July 1, 2005) 65 (5554-5560)).  66:1250. 2006
  • Thymosin β4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblasts.  66:701-712. 2006
  • Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.  65:11259-11264. 2005
  • Loss of phosphatase and tensin homologue increases transforming growth factor β-mediated invasion with enhanced SMAD3 transcriptional activity.  65:11276-11281. 2005
  • Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin.  65:10881-10890. 2005
  • Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.  65:10602-10612. 2005
  • Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses.  65:10214-10222. 2005
  • Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma.  65:10041-10049. 2005
  • Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas.  65:8679-8689. 2005
  • The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro.  65:7603-7611. 2005
  • Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.  65:7194-7204. 2005
  • Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.  65:7370-7377. 2005
  • β1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.  65:6692-6700. 2005
  • Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.  65:5554-5560. 2005
  • Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk.  65:5654-5661. 2005
  • Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.  65:5778-5784. 2005
  • Lyn kinase activity is the predominant cellular Src kinase activity in glioblastoma tumor cells.  65:5535-5543. 2005
  • Hypersialylation of β 1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.  65:4645-4652. 2005
  • The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.  65:4789-4798. 2005
  • High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.  65:4088-4096. 2005
  • Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-κB activity.  65:3586-3595. 2005
  • Mouse models of subcutaneous spleen reservoir for multiple portal venous injections to treat liver malignancies.  65:3823-3827. 2005
  • Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).  65:3328-3335. 2005
  • Mitochondrial damage mediates genotoxicity of arsenic in mammalian cells.  65:3236-3242. 2005
  • RRP22 is a farnesylated, nucleolar, ras-related protein with tumor suppressor potential.  65:3117-3125. 2005
  • Cannabinoid receptor as a novel target for the treatment of prostate cancer.  65:1635-1641. 2005
  • Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells.  65:713-717. 2005
  • Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.  65:1105-1111. 2005
  • Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program.  64:9209-9216. 2004
  • Folate is associated with the natural history of high-risk human papillomaviruses.  64:8788-8793. 2004
  • Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of fas expression and apoptosis.  64:7545-7552. 2004
  • Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.  64:6874-6882. 2004
  • JAGGED1 expression is associated with prostate cancer metastasis and recurrence.  64:6854-6857. 2004
  • Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the Escherichia coli purine nucleoside phosphorylase gene.  64:6610-6615. 2004
  • Transcriptional targeting of adenovirally delivered tumor necrosis factor α by temozolomide in experimental glioblastoma.  64:6381-6384. 2004
  • Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors.  64:5322-5331. 2004
  • Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease.  64:4506-4513. 2004
  • Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.  64:3814-3822. 2004
  • Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun.  64:3772-3779. 2004
  • Selectivity of an Oncolytic Herpes Simplex Virus for Cells Expressing the DF3/MUC1 Antigen.  64:2561-2567. 2004
  • Adeno-Associated Virus 2-Mediated Antiangiogenic Cancer Gene Therapy: Long-Term Efficacy of a Vector Encoding Angiostatin and Endostatin over Vectors Encoding a Single Factor.  64:1781-1787. 2004
  • The Role of Metastasis-Associated Protein 1 in Prostate Cancer Progression.  64:825-829. 2004
  • High Heparanase Activity in Multiple Myeloma Is Associated with Elevated Microvessel Density.  63:8749-8756. 2003
  • Overexpression of the Oncogenic Kinase Pim-1 Leads to Genomic Instability.  63:8079-8084. 2003
  • Tumor necrosis factor α induces angiogenic factor up-regulation in malignant glioma cells: A role for RNA stabilization and HuR.  63:4181-4187. 2003
  • Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells.  63:2631-2637. 2003
  • Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: A Gynecologic Oncology Group Study.  63:1235-1241. 2003
  • Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression.  63:847-853. 2003
  • Melanoma metastasis suppression by chromosome 6: Evidence for a pathway regulated by CRSP3 and TXNIP.  63:432-440. 2003
  • Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation.  62:5867-5873. 2002
  • Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: Differences in integrin signaling during cell adhesion to osteopontin versus vitronectin.  62:5336-5343. 2002
  • Neoglycans, carbodiimide-modified glycosaminoglycans: A new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis.  62:3722-3728. 2002
  • Human cytomegalovirus infection and expression in human malignant glioma.  62:3347-3350. 2002
  • Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples.  62:2699-2707. 2002
  • Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2.  62:1503-1509. 2002
  • High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORγ.  62:901-909. 2002
  • Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.  62:773-780. 2002
  • Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.  61:8866-8872. 2001
  • RNA replicons derived from poliovirus are directly oncolytic for human tumor cells of diverse origins.  61:8470-8479. 2001
  • Profiling of cancer cells using protein microarrays: Discovery of novel radiation-regulated proteins.  61:7585-7593. 2001
  • Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study.  61:7233-7239. 2001
  • Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).  61:6777-6782. 2001
  • Adeno-associated virus for cancer gene therapy.  61:6313-6321. 2001
  • Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule.  61:6377-6381. 2001
  • Tetrasomy is induced by human papillomavirus type 18 e7 gene expression in keratinocyte raft cultures.  61:4858-4863. 2001
  • Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: A poor prognostic factor.  61:4382-4385. 2001
  • The c-Jun NH2-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.  61:4450-4458. 2001
  • Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.  61:3961-3968. 2001
  • Fas-induced expression of chemokines in human glioma cells: Involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.  61:3084-3091. 2001
  • Modulation of biomarkers by chemopreventive agents in smoke-exposed rats.  61:2472-2479. 2001
  • Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication.  61:1765-1767. 2001
  • HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs.  61:2154-2161. 2001
  • Increase of GKLF messenger RNA and protein expression during progression of breast cancer.  60:6488-6495. 2000
  • Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.  60:5599-5602. 2000
  • Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors.  60:4305-4310. 2000
  • Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13.  60:2764-2769. 2000
  • Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells.  60:1552-1556. 2000
  • The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A.  59:5980-5988. 1999
  • Abnormal Fhit expression in malignant and premalignant lesions of the cervix.  59:5270-5274. 1999
  • Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.  59:4559-4563. 1999
  • Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents.  59:4285-4290. 1999
  • Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.  59:3855-3860. 1999
  • Protein kinase C δ involvement in mammary tumor cell metastasis.  59:3230-3238. 1999
  • Genetic and functional analyses exclude mortality factor 4 (MORF4) as a keratinocyte senescence gene.  59:2038-2040. 1999
  • Glioma migration can be blocked by nontoxic inhibitors of myosin II.  59:2076-2082. 1999
  • Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors.  59:2055-2058. 1999
  • Interleukin 8: An autocrine growth factor for malignant mesothelioma.  59:367-371. 1999
  • Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.  58:5738-5748. 1998
  • Use of chlorotoxin for targeting of primary brain tumors.  58:4871-4879. 1998
  • Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.  58:4173-4179. 1998
  • Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects.  58:1893-1900. 1998
  • Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody.  58:1217-1224. 1998
  • Modulation of methylnitrosourea-induced breast cancer in sprague dawley rats by dehydroepiandrosterone: Dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations.  58:921-926. 1998
  • Plasma tocopherol and prevalence of colorectal adenomas in a multiethnic population.  58:661-666. 1998
  • Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.  57:4325-4332. 1997
  • Breast cancer cells have lower activating protein 1 transcription factor activity than normal mammary epithelial cells1.  57:3046-3054. 1997
  • CaN19 expression in benign and malignant hyperplasias of the skin and oral mucosa: Evidence for a role in regenerative differentiation.  57:3055-3062. 1997
  • Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1.  57:2384-2387. 1997
  • FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines.  57:2112-2115. 1997
  • Endometrial hyperplasia and apoptosis following neonatal diethylstilbestrol exposure and subsequent estrogen stimulation in both host and transplanted hamster uteri.  57:1903-1908. 1997
  • Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.  57:1502-1509. 1997
  • Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor.  57:1447-1451. 1997
  • Tamoxifen-mediated growth inhibition of human cholangiocarcinoma.  57:1743-1749. 1997
  • The cell cycle inhibitor p27 is an independent prognostic marker in small (T(1a,b)) invasive breast carcinomas.  57:1259-1263. 1997
  • Mitochondrial genome damage associated with cigarette smoking.  56:5692-5697. 1996
  • Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.  56:3486-3489. 1996
  • Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11.  56:1222-1227. 1996
  • Altered cJun expression: An early event in human lung carcinogenesis.  56:305-315. 1996
  • Correspondence re: G. P. Studzinski and D. C. Moore, Sunlight - Can it prevent as well as cause cancer? Cancer Res., 55: 4014-4022, 1995.  56:925. 1996
  • Experimental approaches to increase radiolabeled antibody localization in tumors.  55. 1995
  • Experimental approaches to increase radiolabeled antibody localization in tumors..  55:5729s-5732s. 1995
  • Fractionated radioimmumotherapy of human colon carcinoma xenografts with131I-labeled monoclonal antibody CC49.  55. 1995
  • Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies.  55. 1995
  • Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies..  55:5893s-5898s. 1995
  • Reconciliation of tumor dose response to external beam radiotherapy versus radioimmunotherapy with 131iodine-labeled antibody for a colon cancer model.  55. 1995
  • Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.  55. 1995
  • Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression..  55:5837s-5841s. 1995
  • Chromosome Band 11q23 Translocation Breakpoints Are DNA Topoisomerase II Cleavage Sites.  55:4287-4292. 1995
  • Phase II Trial of Murine Monoclonal Antibody D612 Combined with Recombinant Human Monocyte Colony-stimulating Factor (rhM-CSF) in Patients with Metastatic Gastrointestinal Cancer.  55:4339-4346. 1995
  • Bystander Killing of Melanoma Cells Using the Human Tyrosinase Promoter to Express the Escherichia coli Purine Nucleoside Phosphorylase Gene.  55:3339-3345. 1995
  • Expression of a Deletion Mutant of the E2F1 Transcription Factor in Fibroblasts Lengthens S Phase and Increases Sensitivity to S Phase-specific Toxins.  55:2883-2891. 1995
  • Neoplastic Reversion Accomplished by High Efficiency Adenoviral-mediated Delivery of an Anti-ras Ribozyme.  55:2024-2028. 1995
  • Enhancement of 5-Fluoro-2′-deoxyuridine Antitumor Efficacy by the Uridine Phosphorylase Inhibitor 5-(Benzyloxybenzyl)barbituric Acid Acyclonucleoside.  55:1092-1098. 1995
  • Characterization of a Messenger RNA Polynucleotide Vaccine Vector.  55:1397-1400. 1995
  • Reactive oxygen species in tumorigenesis..  54:1890s-1894s. 1994
  • Immune Response to a Carcinoembryonic Antigen Polynucleotide Vaccine.  54:1164-1168. 1994
  • Characterization of Poliovirus Replicons Encoding Carcinoembryonic Antigen.  54:6359-6364. 1994
  • Is Tumor Cell Radiation Resistance Correlated with Metastatic Ability?.  54:1736-1741. 1994
  • Potentiation of 5-Fluorouracil Efficacy by the Dihydrouracil Dehydrogenase Inhibitor, 5-Benzyloxybenzyluracil.  54:5166-5170. 1994
  • A Phase I Clinical Trial of Murine Monoclonal Antibody D612 in Patients with Metastatic Gastrointestinal Cancer.  53:4555-4562. 1993
  • In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity..  53:2810-2815. 1993
  • 1-ALPHA,25-DIHYDROXYVITAMIN-D(3) ENHANCES 12-O-TETRADECANOYLPHORBOL-13-ACETATE-INDUCED TUMORIGENIC TRANSFORMATION AND OSTEOPONTIN EXPRESSION IN MOUSE JB6 EPIDERMAL-CELLS.  53:2217-2220. 1993
  • Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma..  53:1906-1910. 1993
  • Differences in Activities and Substrate Specificity of Human and Murine Pyrimidine Nucleoside Phosphorylases: Implications for Chemotherapy with 5-Fluoropyrimidines.  53:3687-3693. 1993
  • Expression of Sulfated Glycoprotein 2 Is Associated with Carcinogenesis Induced by A^Nitroso-AT-methylurea in Rat Prostate and Seminal Vesicle.  53:1480-1483. 1993
  • la,25-Dihydroxyvitamin D3 Enhances 12-0-Tetradecanoylphorbol-13-acetate-induced Tumorigenic Transformation and Osteopontin Expression in Mouse JB6 Epidermal Cells1.  53:2217-2220. 1993
  • p53 and Ki-ras Gene Mutations in Epithelial Ovarian Neoplasms.  53:3103-3108. 1993
  • Application of molecular genetics to the early diagnosis and screening of lung cancer.  52. 1992
  • An Altered 11-Kilobase Transcript in Leukemic Cell Lines with the t(4;11)(q21;q23) chromosome translocation.  52:3811-3813. 1992
  • Characterization of the PML-RARa Chimeric Product of the Acute Promyelocytic Leukemia-specific t(15;17) Translocation.  52:3687-3692. 1992
  • Effect of Systemic Hyperinsulinemia in Cancer Patients.  52:3845-3850. 1992
  • Expression of High-Affinity Laminin Receptor mRNA Correlates with Cell Proliferation Rather Than Invasion in Human Papillomavirus-associated Cervical Neoplasms.  52:1561-1567. 1992
  • Immunogenetic Influences on the Initiation Stage of the Cutaneous Chemical Carcinogenesis Pathway.  52:6106-6109. 1992
  • Improved Delivery of Radiolabeled Anti-Bl Monoclonal Antibody to Raji Lymphoma Xenografts by Predosing with Unlabeled Anti-Bl Monoclonal Antibody.  52:637-642. 1992
  • In Vivo Administration of Bryostatin 1, a Protein Kinase C Activator, Decreases Murine Resistance to Salmonella typhimurium.  52:2143-2147. 1992
  • Lack of T-Cell Immunity in Humans with Preexisting Anti-Mouse Immunoglobulin Reactivity.  52:6979-6982. 1992
  • Phase I Trial of the Murine Monoclonal Anti-GD2 Antibody 14G2a in Metastatic Melanoma.  52:4342-4347. 1992
  • Retinoid Antagonism of Estrogen-responsive Transforming Growth Factor a and pS2 Gene Expression in Breast Carcinoma Cells.  52:3938-3945. 1992
  • Therapy with Unlabeled and 131I-labeled Pan-B-Cell Monoclonal Antibodies in Nude Mice Bearing Raji Burkitt's Lymphoma Xenografts.  52:6476-6481. 1992
  • Pharmacokinetics and Immune Response of 131I-ChimericMouse/Human B72.3 (Human 74) Monoclonal Antibody in Humans.  51:5461-5466. 1991
  • Evidence for the Elevation of Serum Carcinoembryonic Antigen and Tumor-associated Glycoprotein-72 Levels in Patients Administered Interferons.  51:4155-4163. 1991
  • 1α,25-Dihydroxyvitamin D3 Stimulates Synthesis and Secretion of Nonphosphorylated Osteopontin (Secreted Phosphoprotein 1) in Mouse JB6 Epidermal Cells.  51:2144-2150. 1991
  • Radiotherapy in Mice with Yttrium-90-labeled Anti-Ly1 Monoclonal Antibody: Therapy of Established Graft-versus-Host Disease Induced across the Major Histocompatibility Barrier.  51:1891-1897. 1991
  • Radiotherapy in Mice with Yttrium-90-labeled Anti-Ly1 Monoclonal Antibody: Therapy of the T Cell Lymphoma EL4.  51:1883-1890. 1991
  • Coexpression of Different Antigenic Markers on Moieties That Bear CA 125 Determinants.  51:468-475. 1991
  • Photodynamic Therapy Induces Rapid Cell Death by Apoptosis in LSI78Y Mouse Lymphoma Cells.  51:5993-5996. 1991
  • Conditioning: A New Approach to Immunotherapy.  50:4295-4299. 1990
  • Amplification of the c-myc Gene in Human Medulloblastoma Cell Lines and Xenografts.  50:2347-2350. 1990
  • myc Gene Amplification and Expression in Primary Human Neuroblastoma.  50:1459-1463. 1990
  • Glycosphingolipids in Bomirski Transplantable Melanomas in Hamsters.  49:7051-7056. 1989
  • Effect of Dietary Tannic Acid on Epidermal, Lung, and Forestomach Polycyclic Aromatic Hydrocarbon Metabolism and Tumorigenicity in Sencar Mice.  49:5784-5788. 1989
  • Effects of Bryostatins and Retinoic Acid on Phorbol Ester- and Diacylglycerol-induced Squamous Differentiation in Human Tracheobronchial Epithelial Cells.  49:3990-3995. 1989
  • Expression of Human DNA Topoisomerase I in Yeast Cells Lacking Yeast DNA Topoisomerase I: Restoration of Sensitivity of the Cells to the Antitumor Drug Camptothecin.  49:6318-6323. 1989
  • Cytotoxic effects of anti-cd5 radioimmunotoxins on human tumors in vitro and in a nude mouse model.  48:7107-7114. 1988
  • Development and Characterization of a Rat Model for Locally Recurring Mammary Tumors: Sensitivities to 5-Fluoro-2’-deoxyuridine, Adriamycin, and X-Irradiation.  48:4549-4554. 1988
  • Cholesterol Sulfate Accumulation in Tumorigenic and Nontumorigenic Rat Esophageal Epithelial Cells: Evidence for Defective Differentiation Control in Tumorigenic Cells.  48:5289-5295. 1988
  • Formation of Conjugates of 2-Fluoro-β-alanine and Bile Acids during the Metabolism of 5-Fluorouracil and 5-Fluoro-2-deoxyuridine in the Isolated Perfused Rat Liver.  48:2010-2014. 1988
  • Growth of Rat Mammary Adenocarcinoma Cells in Semisolid Clonogenic Medium Not Correlated with Spontaneous Metastatic Behavior: Heterogeneity in the Metastatic, Antigenic, Enzymatic, and Drug Sensitivity Properties of Cells from Different Sized Colonies.  48:399-404. 1988
  • Localization and Imaging of Radiolabeled Monoclonal Antibodies Against Colorectal Carcinoma in Tumor-Bearing Nude Mice.  48:4256-4260. 1988
  • Localization and Imaging with Radioiodine-labeled Monoclonal Antibodies in a Xenogeneic Tumor Model for Human B-Cell Lymphoma.  48:2475-2482. 1988
  • Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice.  48:4324-4333. 1988
  • Properties of L1210 Cells Resistant to α-Difluoro Methyl Or Nithine.  48:2678-2682. 1988
  • Flow Cytometric Analysis of Human Uterine Sarcomas and Cell Lines.  47:2814-2820. 1987
  • Degradation of Basement Membrane Type IV Collagen and Lung Subendothelial Matrix by Rat Mammary Adenocarcinoma Cell Clones of Differing Metastatic Potentials.  47:4869-4876. 1987
  • Induction of Contact Hypersensitivity to Dimethylbenz(a)anthracene and Benzo(a)pyrene in C3N/HeN Mice1.  47:6074-6078. 1987
  • New Benzoic Acid Derivatives with Retinoid Activity: Lack of Direct Correlation between Biological Activity and Binding to Cellular Retinoic Acid Binding Protein.  47:3523-3527. 1987
  • Amplification and Rearrangement of DNA Sequences from the Chromosomal Region 2p24 in Human Neuroblastomas.  46:5297-5301. 1986
  • Immunological suppression in mice treated with hematoporphyrin derivative photoradiation..  46:1608-1611. 1986
  • In Vitro Effect of Monoclonal Anti-ldiotype Antibodies (Anti-M104E) on MOPC 104E Myeloma Cells.  46:1250-1254. 1986
  • Invasiveness and Metastatic Capability of Rat Fibroblast-like Cells before and after Transfection with Immortalizing and Transforming Genes.  46:4787-4795. 1986
  • Enzymes off Uracil Catabolism in Normal and Neoplastic Human Tissues.  45:5405-5412. 1985
  • Control of Polyomavirus T-Antigen and DNA Synthesis in Mouse Embryo Fibroblast Cells by Vitamin A.  45:2098-2102. 1985
  • Local hyperthermia with interstitial techniques..  44:4752s-4756s. 1984
  • Inhibition of Nucleoside Transport in Murine Lymphoma L5178Y Cells and Human Erythrocytes by the Uridine Phosphorylase Inhibitors 5-Benzylacyclouridine and 5-Benzyloxybenzylacyclouridine.  44:3744-3748. 1984
  • Potentiation of 5-Fluoro-2'-deoxyuridine Antineoplastic Activity by the Uridine Phosphorylase Inhibitors Benzylacyclouridine and Benzyloxybenzylacyclouridine.  44:1852-1856. 1984
  • Reduction of Tumor Burden in a Murine Osteosarcoma following Hyperthermia Combined with Cyclophosphamide.  44:1405-1408. 1984
  • Loss of High-Energy Phosphate following Hyperthermia Demonstrated by in Vivo 31P-Nuclear Magnetic Resonance Spectroscopy.  44:633-638. 1984
  • Local hyperthermia with interstitial techniques.  44. 1984
  • Nonrandom Escape of Tumor Cells from Immune Lysis Due to Intraclonal Fluctuations in Antigen Expression.  43:4050-4056. 1983
  • Eosinophil infiltration of human colonic carcinomas as a prognostic indicator.  43:2997-3000. 1983
  • Action of epidermal growth factor and retinoids on anchorage-dependent and-independent growth of nontransformed rat kidney cells.  43:2094-2099. 1983
  • MOPC 104E Plasmacytoma functional heterogeneity and maturational potential in culture.  43:953-958. 1983
  • Tumor proliferation and chemotherapy in immunosuppressed mice.  43:1097-1100. 1983
  • Action of Retinoids on the Anchorage-independent Growth of Normal Rat Kidney Fibroblasts Induced by 12- O-Tetradecanoylphorbol-13-acetate or Sarcoma Growth Factor.  43:68-72. 1983
  • Heterogeneous response and clonal drift of sensitivities of metastatic 13762nf mammary adenocarcinoma clones to ϒ-radiation in vitro.  43:6-10. 1983
  • Inhibitory Effect of L-Homoarginine on Murine Osteosarcoma cell proliferation.  42:1072-1077. 1982
  • Effect of Plasminogen Activator (Urokinase), Piasmin, and Thrombin on Glycoprotein and Collagenous Components of Basement Membrane.  41:4629-4636. 1981
  • Urinary Glycosaminoglycan Excretion as a Biochemical Marker in Patients with Bladder Carcinoma.  41:3868-3873. 1981
  • Effect of Immune Response to Sheep Red Blood Cells on Plasmacytoma MOPC 104 E.  41:2197-2199. 1981
  • Inhibition of Urinary Bladder Cancer by N-(Ethyl)-all-frans-retinamide and N-(2-Hydroxyethyl)-all-trans-retinamide in Rats and Mice.  41:933-936. 1981
  • Maintenance of MOPC 104E Myeloma in Plateau Phase.  40:2372-2376. 1980
  • Relationship between Binding Affinities to Cellular Retinoic Acid-binding Protein and in Vivo and in Vitro Properties for 18 Retinoids.  40:212-220. 1980
  • Distribution of radiolabled alloantibodies in mice bearing 3-methylcholanthrene-induced sarcomas.  39:3363-3368. 1979
  • Comparative Tumor-initiating Activity of Methylated Benzo(a)pyrene Derivatives in Mouse Skin 1.  40:1073-1076. 1979
  • A methodological approach to the prediction of anticancer drug effect in humans.  39:402-407. 1979
  • N-(4-Hydroxyphenyl)retinamide A New Retinoid for Prevention of Breast Cancer in the Rat.  39:1339-1346. 1979
  • An Experimental Approach to Relate a Tumor-associated Enzyme Marker to Tumor Cell Numbers.  37:365-368. 1977
  • Cis-Dichlorodiammineplatinum(II) Chemotherapy in Experimental Murine Myeloma MOPC 104E.  37:771-774. 1977
  • Inhibition of Mammary Cancer by Retinyl Methyl Ether.  37:599-602. 1977
  • Combination versus sequential five drug chemotherapy in metastatic carcinoma of the breast.  36. 1976
  • Inhibition of 7,12-Dimethylbenz(a)anthracene-induced Mammary Carcinogenesis by Retinyl Acetate.  36:2626-2630. 1976
  • Evaluation of a Cooperative Group Human Myeloma Protocol Using the MOPC 104E Myeloma Model.  35:1309-1313. 1975
  • Chemotherapy and Rate of Kill of Tumor Cells in a Mouse Plasmacytoma.  34:1738-1742. 1974
  • Transport of Orally Administered 9, 10-Dimethyl-1, 2-benzanthracene in the Sprague-Dawley Rat.  33:1785-1789. 1973
  • International Standard Serial Number (issn)

  • 0008-5472
  • Electronic International Standard Serial Number (eissn)

  • 1538-7445